Purdue Pharma Strikes Licensing Deal For OxyContin
By Sara Stefanini · September 2, 2008, 12:00 AM EDT
Purdue Pharma LP and generics maker Mallinckrodt Inc. have struck a deal that will allow Mallinckrodt to market and sell its cheaper version of the brand-name painkiller OxyContin for a licensing...
To view the full article, register now.